Genpact (G) has been initiated today with a Outperform rating by the research analysts at Oppenheimer. The firm has also placed a price target of $20 dollars on the company.
The company is currently trading above its 50 & 200-day moving averages. The yearly high for Genpact is $18.71 with the low being $13.09 per share. Gentech has a market cap of $3,584,000,000 with 221,150,000 shares outstanding. The company is trading at an overall gain for 2011.
Genpact (G) a global leader in business process and technology management, offering a broad portfolio of enterprise and industry-specific services. We manage over 3,000 processes for more than 400 clients worldwide.